Mereo BioPharma Group plc - ADR (MREO) is down Thursday morning, with the stock falling -3.63% in pre-market trading to 1.86. MREO's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, MREO ranks higher than 94% of stocks. Mereo BioPharma Group plc - ADR has risen 32.19% over the past month, closing at $1.33 on September 21. During this period of time, the stock fell as low as $1.19 and as high as $1.83. MREO has an average analyst recommendation of Strong Buy. The company has an average price target of $4.33.
News Home
Mereo BioPharma Group plc - ADR has a Long-Term Technical rank of 98. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 2% of the market scoring higher. In the Biotechnology industry which is number 135 by this metric, MREO ranks better than 135% of stocks.
Mereo BioPharma Group plc - ADR (MREO) is down 3.63% Thursday In Premarket Trading
Mentioned in this article
MREO has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on MREO!